検索結果

Quality Policies | About Senju | SENJU Pharmaceutical

Quality Policies We always pay close attention to the quality of our products to provide customers with better pharmaceuticals and comply with laws and standards with high ethical standards on produc...

Central Retinal Artery Occlusion (CRAO). Orphan drugs are designated by the MHLW after consultation with the Pharmaceutical Affairs and Food Sanitation Council as drugs to treat a disease affecting le...

Central Retinal Artery Occlusion (CRAO). Orphan drugs are designated by the MHLW after consultation with the Pharmaceutical Affairs and Food Sanitation Council as drugs to treat a disease affecting le...

ry Eye Disease (DED), has been launched in Japan today. Avarept® represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1) *1 antagonist, designe...

re safer and more reliable use. For this approval, a bioequivalence study was conducted on patients with primary open-angle glaucoma or ocular hypertension, confirming that the new formulation has the...